rts logo

Standard BioTools Inc (LAB) Is Up 19.46% in 2024 With Lots of Room to Run

Standard BioTools Inc (NASDAQ: LAB) is 19.46% higher on its value in year-to-date trading and has touched a low of $1.46 and a high of $3.16 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LAB stock was last observed hovering at around $2.70 in the last trading session, with the day’s loss setting it -0.06%.

Currently trading at $2.64, the stock is -0.58% and 5.95% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.84 million and changing -2.22% at the moment leaves the stock 11.51% off its SMA200. LAB registered 32.66% gain for a year compared to 6-month loss of -8.97%. The firm has a 50-day simple moving average (SMA 50) of $9.34 and a 200-day simple moving average (SMA200) of -$18.23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 5.60% gain in the last 1 month and extending the period to 3 months gives it a 19.46%, and is -2.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.78% over the week and 5.42% over the month.

Standard BioTools Inc (LAB) has around 539 employees, a market worth around $765.92M and $106.34M in sales. Profit margin for the company is -70.21%. Distance from 52-week low is 80.82% and -16.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.79%).

Standard BioTools Inc quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 54.26% this year.

Standard BioTools Inc (LAB) Top Institutional Holders

121 institutions hold shares in Standard BioTools Inc (LAB), with institutional investors hold 56.38% of the company’s shares. The shares outstanding are 290.12M, and float is at 282.68M with Short Float at 3.28%. Institutions hold 56.02% of the Float.

The top institutional shareholder in the company is Caligan Partners, LP with over 8.47 million shares valued at $16.34 million. The investor’s holdings represent 10.72% of the LAB Shares outstanding. As of Jun 29, 2023, the second largest holder is Indaba Capital Management, L.P. with 7.45 million shares valued at $14.37 million to account for 9.43% of the shares outstanding. The other top investors are Neuberger Berman Group, LLC which holds 4.51 million shares representing 5.71% and valued at over $8.69 million, while Vanguard Group Inc holds 4.99% of the shares totaling 3.94 million with a market value of $7.61 million.

Standard BioTools Inc (LAB) Insider Activity

The most recent transaction is an insider purchase by Casdin Partners Master Fund, L,the company’sDirector. SEC filings show that Casdin Partners Master Fund, L bought 1,403 shares of the company’s common stock on Mar 05 ’24 at a price of $2.62 per share for a total of $3669.0. Following the purchase, the insider now owns 11.5 million shares.

Standard BioTools Inc disclosed in a document filed with the SEC on Mar 04 ’24 that Casdin Partners Master Fund, L (Director) bought a total of 250,000 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $2.57 per share for $0.64 million. Following the transaction, the insider now directly holds 11.5 million shares of the LAB stock.

Still, SEC filings show that on May 19 ’23, Casdin Partners Master Fund, L (Director) acquired 800,000 shares at an average price of $2.29 for $1.84 million. The insider now directly holds 1,200,000 shares of Standard BioTools Inc (LAB).

Related Posts